Andorra vs San Marino: Number of deaths from cardiovascular diseases by type
Andorra
0.76 deaths
in 2021
San Marino
0.9 deaths
in 2021
Andorra rank
186th
San Marino rank
185th
Number of deaths from cardiovascular diseases by type over time
- Andorra
- San Marino
How they compare
San Marino currently reports 0.9 deaths against 0.76 deaths in Andorra, a difference of 0.14 deaths.
That makes San Marino's figure about 1.2 times Andorra's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was San Marino ahead.
Andorra ranks 186th and San Marino ranks 185th of 194 countries.
Across the 3 decades both report, Andorra averaged higher in 1 and San Marino in 2.
Head to head by decade
| Decade | Andorra | San Marino | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.987 deaths | 0.933 deaths | 0.054 deaths | Andorra |
| 2010s | 0.872 deaths | 1.19 deaths | 0.32 deaths | San Marino |
| 2020s | 0.72 deaths | 0.885 deaths | 0.165 deaths | San Marino |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of deaths from cardiovascular diseases by type, Andorra or San Marino?
- San Marino, at 0.9 deaths against 0.76 deaths in Andorra as of 2021.
- What is the difference in number of deaths from cardiovascular diseases by type between Andorra and San Marino?
- 0.14 deaths, with San Marino ahead.
- How many years of comparable data are there for Andorra and San Marino?
- 22 years are reported by both, from 2000 to 2021.
- How do Andorra and San Marino rank globally for number of deaths from cardiovascular diseases by type?
- Andorra ranks 186th and San Marino ranks 185th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Number of deaths from cardiovascular diseases by type. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from rheumatic heart disease in both sexes.